BioRegion at the leading global event for the sector
This year once again, Biocat coordinated the participation of companies and entities in the BioRegion of Catalonia at the BIO International Convention, the leading global event for the sector, which took place from 19-22 June 2017, in San Diego, California. In the Spanish pavilion coordinated by ICEX, the BioRegion of Catalonia had a booth of more than 30 m2, within which five Catalan companies (BCN Peptides, Oryzon Genomics, Salvat Biotech, Trifermed and ZeClinics) had their own space.
A total of 46 delegates from 30 Catalan companies and entities participated in the fair. Specifically, the Catalan delegation in San Diego was formed by 8 biotech companies focused on therapies and diagnostics, 7 dedicated to research and development services, 6 pharmaceutical companies, 1 professional services and consulting company and 1 company dedicated to risk capital, together with 7 seven entities.
Visibility in the fair’s program
To maximize the visibility of the BioRegion of Catalonia at the BIO International Convention, a global benchmark partnering fair for the biopharma sector, Biocat organized several activities during the event.
Thus, Biocat presented the main assets of the BioRegion of Catalonia at the International Cancer Cluster Showcase (ICCS), a BIO satellite event with ACCIÓ and Biocat as partners, during which several international bioregions presented their innovations in oncology and leading-edge business projects. In addition to Biocat’s presentation, Catalan companies Ability Pharmaceuticals and ZeClinics also presented their projects. Biocat also participated in the Global Innovation Hubs sessions to highlight the opportunities offered by the BioRegion to companies around the world and to attract foreign investment.
Furthermore, Oryzon Genomics gave its own business presentation during the fair's program, explaining its new developments regarding the selective LSD1 inhibitor, ORY-1001, aimed at patients with acute leukemia.
The Catalan companies and entities, according to the area of activity and the entities that attended the fair, either on their own behalf or under the coordination of Biocat, were as follows:
Professional and Consultancy Services: TrifermedCBDO
Entities: Biocat, Catalonia Trade & Investment – ACCIÓ, Center for Genomic Regulation, Germans Trias i Pujol Research Institute, Barcelona Science Park, Institute for Research in Biomedicine and Vall d’Hebron Research Institute.
Venture capital: Alta Life Sciences